Viewing Study NCT05309668


Ignite Creation Date: 2025-12-24 @ 5:32 PM
Ignite Modification Date: 2026-01-01 @ 2:01 PM
Study NCT ID: NCT05309668
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-12-18
First Post: 2021-11-26
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Pharmacokinetics, Safety and Efficacy of the Selumetinib Granule Formulation in Children Aged ≥1 to <7 Years With NF1-related Symptomatic, Inoperable PN
Sponsor: AstraZeneca
Organization: